- Home
- BCG vs ICCM Comparison
BCG vs ICCM Comparison
Compare BCG & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BCG | ICCM |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8M | 43.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BCG | ICCM |
|---|---|---|
| Price | $2.45 | $0.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 29.7K | ★ 326.3K |
| Earning Date | 11-13-2025 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $178,203,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $19.87 |
| Revenue Next Year | N/A | $31.38 |
| P/E Ratio | $69.41 | ★ N/A |
| Revenue Growth | ★ 10.19 | N/A |
| 52 Week Low | $1.36 | $0.58 |
| 52 Week High | $5.81 | $1.66 |
Technical Indicators
Market Signals| Indicator | BCG | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 49.82 | 44.37 |
| Support Level | $2.25 | $0.63 |
| Resistance Level | $2.68 | $0.68 |
| Average True Range (ATR) | 0.22 | 0.04 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 29.08 | 15.19 |
Price Performance
Historical ComparisonAbout BCG Binah Capital Group Inc.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.